Business Context and Reporting Period
Chijet Motor Company, Inc. filed a Form 6-K for June 2023, signed June 7, 2023. The filing reports the closing of its business combination with Jupiter Wellness Acquisition Corp. (“JWAC”) on June 1, 2023. The filing company is Chijet Motor Company, Inc.; the request metadata identifies a different company name.
Following the transaction, Chijet became a wholly owned subsidiary of Chijet Motor Company, Inc. (“Pubco”), and JWAC became a wholly owned subsidiary of Pubco. Pubco Ordinary Shares began trading on Nasdaq Global Market on June 2, 2023 under the ticker “CJET.”
Key Financial and Capitalization Information
| Item | Reported information |
|---|---|
| Exchange consideration | Sellers received 152,130,300 Pubco Ordinary Shares with an aggregate stated value of approximately $1.6 billion, based on a redemption price of approximately $10.517 per share. |
| Potential earnout adjustment | Consideration may be reduced by up to $674 million through the surrender of shares, based on specified post-closing financial performance and share-price metrics. |
| Shares outstanding after closing | 160,359,631 Pubco Ordinary Shares were issued and outstanding immediately after the transactions described in the filing. |
| Public stockholder shares | Approximately 1,300,706 Pubco Ordinary Shares were issued in exchange for JWAC public shares, together with one private contingent value right per share. |
| Other securities | JWAC rights and privately held securities were exchanged for Pubco securities. A Greentree warrant covering 5,000,000 shares was exchanged and partially exercised for 250,000 shares; a representative warrant covered 414,000 shares. |
| Operating results and liquidity | The filing does not provide current-period revenue, profit, cash flow, margins, debt, cash balances, or liquidity metrics. |
Material Changes Versus the Prior Comparable Period
- The principal reported change is the completion of the business combination and the resulting change in corporate structure, ownership, securities, and Nasdaq listing.
- Pubco adopted amended and restated memorandum and articles of association under Cayman Islands law.
- JWAC-related warrants and other contractual rights were assumed, exchanged, or amended by Pubco.
- The filing does not present comparative operating or financial results, so changes in revenue, profitability, cash flow, debt, or margins cannot be assessed from this filing.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- Contingent value rights may result in the release of Pubco Ordinary Shares upon satisfaction of specified revenue and share-price conditions. The rights are generally nontransferable, subject to limited exceptions.
- Earnout provisions may reduce the sellers’ consideration by up to $674 million based on future financial performance and stock-price metrics.
- Certain sellers are subject to six-month lock-up restrictions. For 50% of covered shares, restrictions may end earlier if the share price reaches $12.50 for 20 days within a 30-day trading period.
- Registration rights were granted for specified Pubco securities, subject to applicable lock-ups and transfer restrictions.
- Certain sellers agreed to 18-month noncompetition and nonsolicitation restrictions following closing.
- Management cautions that forward-looking statements are subject to risks and uncertainties described in the Merger Proxy Statement, including the risk factors and management’s discussion and analysis incorporated by reference.
- No specific financial guidance or quantitative operating outlook is provided in this Form 6-K.
Investor Verification Checklist
- Verify the final post-closing share count, including any shares subject to earnout surrender and subsequent warrant exercises.
- Review the CVR Agreement and earnout provisions to determine the revenue, share-price, and performance conditions that could affect future dilution or consideration.
- Review the company’s subsequent SEC filings for historical financial statements, cash and liquidity, debt, operating performance, and going-concern disclosures.
- Confirm the terms and expiration of seller lock-ups, registration rights, warrants, and other potentially dilutive securities.
- Read the incorporated Merger Proxy Statement risk factors and management discussion for operational, transaction, market, and regulatory risks not detailed in this filing.